Clinical Trials Logo

Clinical Trial Summary

A double-blind, randomized, placebo-controlled, multi-center, phase III study to evaluate the efficacy and safety of LIZTOX in subjects with benign massesric hypertrophy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05964257
Study type Interventional
Source Huons Biopharma
Contact Ham kiltae
Phone +82-02-854-4700
Email kiltae.ham@HUONS.COM
Status Recruiting
Phase Phase 3
Start date July 25, 2023
Completion date May 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT04443244 - Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy Phase 2
Completed NCT04294251 - Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy Phase 3
Not yet recruiting NCT03369990 - DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy Phase 2